A Win For Ampio Pharmaceuticals, Inc.
Fri, Nov 18, 2022 at 07:27 PM
Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) rocketted at $0.03, representing a gain of 28.3%. On Fri, Nov 18, 2022, AMPE:NYSEMKT hit a New 2-Week Intraday Low of $0.02. The stock got featured on our News Catalysts scanner on Tue, Nov 08, 2022 at 07:22 PM in the 'SPLIT' category. From Fri, Nov 04, 2022, the stock recorded 10.00% Up Days and 27.27% Green Days
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- FedNat Holding Company (FNHC:NASDAQ), 91.67%
- AGBA Acquisition Limited (AGBA:NASDAQ), 50.67%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 46.85%
- PaxMedica Inc. (PXMD:NASDAQ), 37.42%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 32.91%
- Yatra Online, Inc. (YTRA:NASDAQ), 32.55%
- XL Group Ltd (XL:NYSE), 30.91%
- Stryve Foods Inc. (SNAX:NASDAQ), 28.62%
- Conformis, Inc. (CFMS:NASDAQ), 28.48%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%